Unum Group (UNM) Q4 2025 earnings review
Core Margins Deteriorate as Accounting Changes Loom
Unum's Q4 2025 results revealed a troubling crack in its core engine. While top-line premium revenue grew 2.3%, profitability in the primary Unum US segment slumped 13.1% due to a spike in benefit ratios (claims). Adjusted Operating EPS of $1.92 fell 5.4% YoY. Management is pivoting the narrative for 2026 by excluding the volatile 'Closed Block' from adjusted earnings, aiming for 8-12% growth off a redefined base. However, the immediate reality is a core business facing pressure from higher claim severity and lower investment income.
🐂 Bull Case
The International segment is firing on all cylinders, with premium income up 17.1% YoY and sales jumping 17.5%. Unum UK and Poland are delivering double-digit growth, diversifying the revenue base away from the saturated US market.
Unum remains a cash machine. The company returned $1.3B to shareholders in 2025 (buybacks + dividends) and maintains a robust capital position with holding company liquidity of $2.3B and an RBC ratio of ~440%.
🐻 Bear Case
Unum US Group Disability—the company's profit engine—saw adjusted operating income collapse 30.2% YoY. The benefit ratio spiked to 64.2% (vs 60.4% prior year) due to higher claim sizes and lower mortality resolutions.
High-margin Group Long-Term Disability (LTD) sales fell 17.7%. While Short-Term Disability sales surged 45%, this mix shift often implies lower long-term stickiness and margin potential.
⚖️ Verdict: 🔴
Bearish. The 'redefined' guidance for 2026 masks a significant deterioration in Q4 core fundamentals. When the primary profit driver (US Disability) sees income drop 30% and margins compress by 400bps, the stock warrants caution until claim trends stabilize.
Key Themes
Unum US Group Disability Profit Squeeze
The most alarming metric in the report is the deterioration of the Unum US Group Disability line. Adjusted operating income fell from $146.5M in 24Q4 to $102.3M in 25Q4 (-30%). This was driven by a sharp rise in the Benefit Ratio to 64.2%. Management cited 'claim size' and 'lower resolutions driven by mortality,' suggesting existing claims are becoming costlier and sticking around longer.
Investment Income Headwinds
Net Investment Income in the core Unum US segment dropped 5.0% YoY to $148.3M. Yields on invested assets are decreasing, creating a headwind that operational efficiency must offset—which it failed to do this quarter.
International Growth Engine
Unum International is the clear growth outlier. Premium income grew 17.1% to $283.9M. While operating income was dampened by investment returns, the top-line demand in the UK and Poland remains robust, with sales growing 17.5% YoY.
Accounting Shift: Excluding the Closed Block
Starting in 2026, Unum will exclude the 'Closed Block' (legacy long-term care policies) from its Adjusted Operating Income. This is a strategic move to reduce volatility and highlight core performance. However, it complicates comparisons: reported FY25 EPS was $8.13, but the 'redefined' baseline for 2026 growth is $7.93.
Colonial Life Stagnation
Colonial Life operating income dropped 7.2% YoY. While premiums grew a modest 3.2%, the benefit ratio deteriorated to 48.3% from 46.8%, driven by unfavorable experience in life and accident/sickness lines. This segment is struggling to expand margins.
Other KPIs
Stable. Up 3.3% YoY from $75.51. This slow growth reflects the heavy impact of capital returns (buybacks/dividends) and the earnings miss in Q4, but remains a solid anchor for valuation.
Decelerating. Sales dropped 17.7% YoY. This is a high-margin product line, and a double-digit decline in new business generation suggests competitive pressures or pricing discipline that is hurting volume.
Accelerating. Up 45.3% YoY. The mix shift toward short-term disability is pronounced. While it drives revenue now, these policies typically have lower lifetime value than LTD contracts.
Guidance
Accelerating (vs Redefined Base). Management projects 8-12% growth off the 'redefined' 2025 base of $7.93 (which excludes Closed Block). If compared to the reported FY25 EPS of $8.13, the growth is closer to 6-9%.
Accelerating. This target is aggressive compared to the 2.9% reported growth for Unum US in FY25, implying confidence in sales acceleration or strong persistency/pricing actions in 2026.
Key Questions
Sustainability of Group Disability Margins
The Benefit Ratio in Group Disability jumped to 64.2%, well above the 60.4% seen last year. Is this 'claim size' issue a one-quarter anomaly or a structural reset of margins back to pre-pandemic levels?
Long-Term Disability Sales Drop
Group LTD sales fell nearly 18% YoY. Is Unum losing market share to aggressive pricing from competitors, and does the pivot to Short-Term Disability sales (up 45%) negatively impact long-term embedded value?
Colonial Life Margin Compression
Colonial Life income fell 7% despite sales growth. What specific drivers caused the benefit ratio to deteriorate in life and accident lines, and are these pricing issues that will persist into 2026?